United Therapeutics Corp. (UTHR)
492.21
-20.49
(-4.00%)
USD |
NASDAQ |
Sep 02, 16:00
492.21
0.00 (0.00%)
After-Hours: 16:22
United Therapeutics Cash from Investing (Quarterly) : 87.50M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.50M |
| March 31, 2026 | 743.70M |
| December 31, 2025 | -227.60M |
| September 30, 2025 | 140.90M |
| June 30, 2025 | -299.90M |
| March 31, 2025 | -164.70M |
| December 31, 2024 | -123.20M |
| September 30, 2024 | -114.90M |
| June 30, 2024 | -80.00M |
| March 31, 2024 | 735.30M |
| December 31, 2023 | 42.10M |
| September 30, 2023 | -313.40M |
| June 30, 2023 | -227.20M |
| March 31, 2023 | -221.10M |
| December 31, 2022 | -189.30M |
| September 30, 2022 | -94.00M |
| June 30, 2022 | -169.00M |
| March 31, 2022 | -359.20M |
| December 31, 2021 | -195.80M |
| September 30, 2021 | -235.90M |
| June 30, 2021 | -48.90M |
| March 31, 2021 | -6.30M |
| December 31, 2020 | -63.80M |
| September 30, 2020 | -271.70M |
| June 30, 2020 | -375.40M |
| Date | Value |
|---|---|
| March 31, 2020 | -27.60M |
| December 31, 2019 | 66.20M |
| September 30, 2019 | -298.70M |
| June 30, 2019 | -42.60M |
| March 31, 2019 | -60.30M |
| December 31, 2018 | -105.20M |
| September 30, 2018 | -296.90M |
| June 30, 2018 | -359.80M |
| March 31, 2018 | -58.70M |
| December 31, 2017 | -278.40M |
| September 30, 2017 | -200.20M |
| June 30, 2017 | -191.40M |
| March 31, 2017 | -165.60M |
| December 31, 2016 | 8.50M |
| September 30, 2016 | 20.10M |
| June 30, 2016 | 7.70M |
| March 31, 2016 | 12.00M |
| December 31, 2015 | 56.41M |
| September 30, 2015 | 347.65M |
| June 30, 2015 | 31.07M |
| March 31, 2015 | 68.46M |
| December 31, 2014 | 51.96M |
| September 30, 2014 | 97.95M |
| June 30, 2014 | 82.18M |
| March 31, 2014 | 106.38M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Liquidia Corp. | -12.24M |
| MannKind Corp. | 17.91M |
| Vertex Pharmaceuticals, Inc. | -45.80M |
| Savara, Inc. | 32.60M |
| Exelixis, Inc. | 91.43M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 310.20M |
| Cash from Financing (Quarterly) | 125.80M |
| Free Cash Flow | 1.084B |
| Free Cash Flow Per Share (Quarterly) | 4.415 |
| Free Cash Flow to Equity (Quarterly) | 202.20M |
| Free Cash Flow to Firm (Quarterly) | 204.79M |
| Free Cash Flow Yield | 4.70% |